Search

Author/Creator Baik, S. H.

1. A multicentre, multinational, randomized, placebo‐controlled, double‐blind, phase 3 trial to evaluate the efficacy and safety of gemigliptin (LC15‐0444) in patients with type 2 diabetes. Issue 5 (17th December 2012)

Authors:
Yang, S. J.; Min, K. W.; Gupta, S. K.; Park, J. Y.; Shivane, V. K.; Pitale, S. U.; Agarwal, P. K.; Sosale, A.; Gandhi, P.; Dharmalingam, M.; Mohan, V.; Mahesh, U.; Kim, D. M.; Kim, Y. S.; Kim, J. A.; Kim, P. K.; Baik, S. H.
Journal:
Diabetes, obesity & metabolism
Issue:
Volume 15:Issue 5(2013:May)
Page Start:
410
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Anagliptin and sitagliptin as add‐ons to metformin for patients with type 2 diabetes: a 24‐week, multicentre, randomized, double‐blind, active‐controlled, phase III clinical trial with a 28‐week extension. Issue 5 (14th January 2015)

Authors:
Jin, S.‐M.; Park, S. W.; Yoon, K.‐H.; Min, K. W.; Song, K.‐H.; Park, K. S.; Park, J.‐Y.; Park, I. B.; Chung, C. H.; Baik, S. H.; Choi, S. H.; Lee, H. W.; Lee, I.‐K.; Kim, D.‐M.; Lee, M.‐K.
Journal:
Diabetes, obesity & metabolism
Issue:
Volume 17:Issue 5(2015:May)
Page Start:
511
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Efficacy and safety of glimepiride/metformin sustained release once daily vs. glimepiride/metformin twice daily in patients with type 2 diabetes. Issue 3 (22nd January 2013)

Authors:
Hwang, Y.‐C.; Kang, M.; Ahn, C. W.; Park, J. S.; Baik, S. H.; Chung, D. J.; Jang, H. C.; Kim, K.‐A.; Lee, I.‐K.; Min, K. W.; Nam, M.; Park, T. S.; Son, S. M.; Sung, Y.‐A.; Woo, J.‐T.; Park, K. S.; Lee, M.‐K.
Journal:
International journal of clinical practice
Issue:
Volume 67:Issue 3(2013)
Page Start:
236
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Lobeglitazone and pioglitazone as add‐ons to metformin for patients with type 2 diabetes: a 24‐week, multicentre, randomized, double‐blind, parallel‐group, active‐controlled, phase III clinical trial with a 28‐week extension. Issue 6 (8th February 2015)

Authors:
Jin, S.‐M.; Park, C.‐Y.; Cho, Y. M.; Ku, B. J.; Ahn, C. W.; Cha, B.‐S.; Min, K. W.; Sung, Y. A.; Baik, S. H.; Lee, K. W.; Yoon, K.‐H.; Lee, M.‐K.; Park, S. W.
Journal:
Diabetes, obesity & metabolism
Issue:
Volume 17:Issue 6(2015:Jun.)
Page Start:
599
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Lobeglitazone and pioglitazone as add‐ons to metformin for patients with type 2 diabetes: a 24‐week, multicentre, randomized, double‐blind, parallel‐group, active‐controlled, phase III clinical trial with a 28‐week extension. Issue 6 (8th February 2015)

Authors:
Jin, S.‐M.; Park, C.‐Y.; Cho, Y. M.; Ku, B. J.; Ahn, C. W.; Cha, B.‐S.; Min, K. W.; Sung, Y. A.; Baik, S. H.; Lee, K. W.; Yoon, K.‐H.; Lee, M.‐K.; Park, S. W.
Journal:
Diabetes, obesity & metabolism
Issue:
Volume 17:Issue 6(2015:Jun.)
Page Start:
599
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗